Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon®)

MLA

Boris I. Gorin, et al. “Differences in Bioavailability and Cognitive-Enhancing Activity Exerted by Different Crystal Polymorphs of Latrepirdine (Dimebon®).” Frontiers in Pharmacology, vol. 14, Feb. 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1091858.

APA

Boris I. Gorin, Elena A. Tukhovskaya, Alina M. Ismailova, Gulsara A. Slashcheva, Oksana A. Lenina, Konstantin A. Petrov, Ilya V. Kazeev, & Arkady N. Murashev. (2023). Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon®). Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1091858

Chicago

Boris I. Gorin, Elena A. Tukhovskaya, Alina M. Ismailova, Gulsara A. Slashcheva, Oksana A. Lenina, Konstantin A. Petrov, Ilya V. Kazeev, and Arkady N. Murashev. 2023. “Differences in Bioavailability and Cognitive-Enhancing Activity Exerted by Different Crystal Polymorphs of Latrepirdine (Dimebon®).” Frontiers in Pharmacology 14 (February). doi:10.3389/fphar.2023.1091858.